Real-world treatment and outcomes of ALK-positive metastatic non–small cell lung cancer in a southeast Asian country

Purpose: Anaplastic lymphoma kinase (ALK) inhibitors are associated with good overall survival (OS) for ALK-positive metastatic non–small cell lung cancer (NSCLC). However, these treatments can be unavailable or limited by financial constraints in developing countries. Using data from a nationwide...

Full description

Bibliographic Details

Main Authors:	Poh, Mau Ern, How, Soon Hin, Ho, Gwo Fuang, Pang, Yong Kek, Hasbullah, Harissa H, Tho, Lye Mun, Muhamad Nor, Ibtisam, Lim, Bee Chiu Lim, Ho, Kean Fatt, Thiagarajan, Muthukkumaran, Samsudin, Azlina, Omar, Azza, Ong, Choo Khoon, Soon, Sing Yang, Kuan Tan, Justin Yu, Zainal Abidin, Muhammad Adil
Format:	Article
Language:	en en
Published:	Dove Medical Press 2023
Subjects:	RC270 Neoplasms. Tumors. Oncology-Cancer and Other Malignant Neoplasms-Therapeutics
Online Access:	http://irep.iium.edu.my/103209/2/103209_Real-world%20treatment%20and%20outcomes.pdf http://irep.iium.edu.my/103209/8/103209_Real-world%20treatment%20and%20outcomes_Scopus.pdf http://irep.iium.edu.my/103209/ https://www.dovepress.com/articles.php?article_id=80981#
Tags:	Add Tag No Tags, Be the first to tag this record!